Form 4 holding
Director
CNS Pharmaceuticals, Inc.
- Security class
- Option to purchase common stock
- Shares / value
- 45,428
- Estimated value
- Report date
- 21 Sep 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount